Last update 24 May 2025

Fluorometholone/Sulfacetamide Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
FML-S
Target
DHPS x GR
Action
inhibitors, agonists
Mechanism
DHPS inhibitors(Dihydropteroate synthase inhibitors), GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Infectious DiseasesEye DiseasesOther Diseases
Active Indication-
Inactive Indication
Eye Infections, BacterialOcular inflammation
Originator Organization
Allergan UC
Active Organization-
Inactive Organization
Allergan, Inc.
License Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (29 Sep 1989),
Eye Infections, BacterialOcular inflammation
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC30H39FN2NaO7S
InChIKeyDDGDRHLMLMPNRS-LGZBILFYSA-N
CAS Registry288392-53-0

Related

1
Clinical Trials associated with Fluorometholone/Sulfacetamide Sodium
NCT02051023
/ CompletedPhase 3IIT
Randomized, Double-Masked, Vehicle-controlled Phase III Trial on the Safety/Efficacy of FML® 0.1% in the Treatment of the Inflammatory Exacerbation Provoked by Exposure to an Adverse Controlled Environment in Patients With Dry Eye Disease
100 Clinical Results associated with Fluorometholone/Sulfacetamide Sodium
Login to view more data
100 Translational Medicine associated with Fluorometholone/Sulfacetamide Sodium
Login to view more data
100 Patents (Medical) associated with Fluorometholone/Sulfacetamide Sodium
Login to view more data
100 Deals associated with Fluorometholone/Sulfacetamide Sodium
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Eye Infections, Bacterial
United States
Allergan, Inc.
29 Sep 1989
Ocular inflammation
United States
Allergan, Inc.
29 Sep 1989
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free